Background Nebulized particles must have diameters between 1 to 5 μ m (optimal particle
size range [OPSR]) to be deposited in the lower respiratory tract. The purpose of this study is …

Study Objectives Albuterol and other asthma medications are commonly delivered to the
lungs via nebulization. Particle sizes from the nebulization process should ideally be in the …

BACKGROUND: Various studies have demonstrated the benefits of continuous nebulization
therapy for delivering aerosols of the beta2 agonists such as terbutaline sulfate or albuterol …

Background and objectives: Continuous albuterol nebulization (CAN) is a therapeutic
modality available to treat status asthmaticus. Currently, CAN may be administered using a …

BACKGROUND: Continuous albuterol nebulization has become the standard of care for
patients with status asthmaticus. Predictable albuterol delivery is paramount for effective …

Background Medication nebulizers are commonly used to delivery aerosolized medications
to patients with respiratory disease. We evaluated output and respirable aerosol available to …

OBJECTIVES: Different commercially available nebulizers and compressors are available.
However, the optimal combination for drug delivery is unknown. METHODS: Flow rates of …

Aerosol particle size influences airway drug deposition. Current inhaler devices are
inefficient, delivering a heterodisperse distribution of drug particle sizes where, at best, 20 …

BACKGROUND: Continuous nebulization is a safe and practical method of administration of
beta2-adrenergic agonists during acute asthma. There are essentially 2 types of continuous …

BACKGROUND: The purpose of this study was to evaluate how factors (ambient
temperature, shaking the inhaler before use, suspension of the inhaler in water, and the …